title: What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?
authors.affiliation: Department of Gastroenterology, Dokuz Eylül University, School of Medicine, İzmir, Turkey. goksel.bengi@deu.edu.tr
authors.forename: Göksel
authors.initials: G
authors.lastname: Bengi
authors.forename: Hale
authors.initials: H
authors.lastname: Akpinar
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D004351:Drug Resistance; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D012720:Severity of Illness Index
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069285:Infliximab